As previously reported on this blog, Cleveland Clinic researchers have launched the first clinical trial to examine the use of deep brain stimulation (DBS) to promote motor function recovery in disabled stroke survivors.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
The trial’s lead investigator, neurosurgeon Andre Machado, MD, PhD, recently shared some insights on the trial’s clinical implications in this video post.
Now co-investigator Kenneth Baker, PhD, assistant staff in Cleveland Clinic’s Department of Neurosciences, speaks to some of the scientific implications of the study’s attempt to stimulate the brain’s dentatothalamocortical pathway to restore lost motor function. He also explains how Cleveland Clinic’s recent NIH BRAIN (Brain Research through Advancing Innovative Neurotechnologies) grant award is supporting the team’s work.
Check out his insights in the video below.